Simao, F., Matte, A., Pagnussat, A.S., Netto, C.A. and Salbego, C.G. (2012) Resveratrol Prevents CA1 Neurons against Ischemic Injury by Parallel Modulation of Both GSK-3β and CREB through PI3-K/Akt Pathways. European Journal of Neuroscience, 36, 2899-2905.
http://dx.doi.org/10.1111/j.1460-9568.2012.08229.x

has been cited by the following article:

• TITLE: Review on the Effect of Resveratrol on Central Nervous System Disease

  AUTHORS: Wenzhe Dong, Yan Zhou, Zhifang Yang

  KEYWORDS: Resveratrol, Central Nervous System Diseases, Disease Treatment, Alzheimer’s Disease

  JOURNAL NAME: Journal of Behavioral and Brain Science, Vol.6 No.3, March 25, 2016

  ABSTRACT: Resveratrol (3,5,4’-trihydroxy-trans-stilbene, RV) is a kind of phytoalexin found in many kinds of plants and food. As a natural antioxidant, RV shows significant biological activity, including anti-tumor activity, antitubulin activity, cardiovascular disease resistance activity, etc. Many experiments confirm that resveratrol displays a wide range of beneficial effects on human diseases including heart disease and cancer, especially in the treatment of central nervous system disease, such as Huntington’s disease (HD), Alzheimer’s disease (AD) and Parkinson’s disease (PD). This paper summarizes the positive effects of RV on several central nervous system diseases.